B

Beijing Winsunny Pharmaceutical Co Ltd
SSE:601089

Watchlist Manager
Beijing Winsunny Pharmaceutical Co Ltd
SSE:601089
Watchlist
Price: 27.24 CNY -2.58% Market Closed
Market Cap: ¥5.2B

Operating Margin

14.6%
Current
Improving
by 0.1%
vs 3-y average of 14.5%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
14.6%
=
Operating Income
¥500.1m
/
Revenue
¥3.4B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
14.6%
=
Operating Income
¥500.1m
/
Revenue
¥3.4B

Peer Comparison

Country Company Market Cap Operating
Margin
CN
Beijing Winsunny Pharmaceutical Co Ltd
SSE:601089
5.2B CNY
Loading...
US
Eli Lilly and Co
NYSE:LLY
978.7B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
547.3B USD
Loading...
CH
Roche Holding AG
SIX:ROG
277.3B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
210B GBP
Loading...
CH
Novartis AG
SIX:NOVN
220.8B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
273B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.6T DKK
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
150.2B USD
Loading...
FR
Sanofi SA
PAR:SAN
95.7B EUR
Loading...

Market Distribution

Higher than 80% of companies in China
Percentile
80th
Based on 8 544 companies
80th percentile
14.6%
Low
-409 046.1% — -1.4%
Typical Range
-1.4% — 10.3%
High
10.3% — 876.4%
Distribution Statistics
China
Min -409 046.1%
30th Percentile -1.4%
Median 4.2%
70th Percentile 10.3%
Max 876.4%

Beijing Winsunny Pharmaceutical Co Ltd
Glance View

Market Cap
5.2B CNY
Industry
Pharmaceuticals

In the bustling epicenter of China's pharmaceutical landscape lies Beijing Winsunny Pharmaceutical Co Ltd, a dynamic player that expertly navigates the intricacies of modern healthcare needs. Established as a frontrunner in the production of both active pharmaceutical ingredients (APIs) and finished dosage forms, Winsunny has carved out a niche by marrying traditional pharmaceutical craftsmanship with innovative technological advancements. The company focuses predominantly on the cardiovascular and gastrointestinal therapeutic segments, diligently working to bring cutting-edge treatments to global markets. Leveraging state-of-the-art research and development facilities, Winsunny fosters a culture of continuous innovation and stringent quality assurance, ensuring its offerings not only meet but often exceed regulatory requirements. This emphasis on quality and innovation anchors its reputation as a reliable partner in the pharmaceutical supply chain, both within China and internationally. Winsunny's financial health and traction in the market are built upon a versatile business model that capitalizes on both proprietary research and strategic partnerships. By investing heavily in R&D, the company pioneers new drugs while simultaneously improving existing formulations to enhance efficacy and safety profiles. Furthermore, Winsunny’s strategic alliances with global pharmaceutical giants enable it to expand its market reach and distribution networks. This synergistic approach, coupled with a keen eye on operational efficiencies, allows Winsunny to maintain competitive pricing without compromising on quality. As healthcare demands continue to evolve, the company stands agile, ready to adapt and address these shifts, ensuring its place as a stalwart in the pharmaceutical industry and a significant contributor to global health advancements.

Intrinsic Value
35.4 CNY
Undervaluation 23%
Intrinsic Value
Price
B
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
14.6%
=
Operating Income
¥500.1m
/
Revenue
¥3.4B
What is Beijing Winsunny Pharmaceutical Co Ltd's current Operating Margin?

The current Operating Margin for Beijing Winsunny Pharmaceutical Co Ltd is 14.6%, which is above its 3-year median of 14.5%.

How has Operating Margin changed over time?

Over the last 3 years, Beijing Winsunny Pharmaceutical Co Ltd’s Operating Margin has increased from 13.1% to 14.6%. During this period, it reached a low of 13% on Sep 30, 2022 and a high of 15.3% on Jun 30, 2024.

Back to Top